HOB Biotech Group Corp.,Ltd

SSE:688656.SS

134.28 (CNY) • At close June 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016
Revenue 402.339394.406320.392317.708221.857259.127201.446146.32111.6
Cost of Revenue 145.156149.413118.13698.54676.482.73359.15844.30538.343
Gross Profit 257.183244.993202.256219.161145.457176.394142.289102.01473.257
Gross Profit Ratio 0.6390.6210.6310.690.6560.6810.7060.6970.656
Reseach & Development Expenses 46.26947.00938.74131.78624.13125.43924.15319.68723.348
General & Administrative Expenses 27.21911.4749.8879.2683.78410.3156.834.74712.737
Selling & Marketing Expenses 31.89893.87978.65768.0550.08154.71842.36535.63131.262
SG&A 59.117105.57288.54477.31853.86565.03349.19540.37943.999
Other Expenses 110.415032.22423.64815.35515.137-2.5180.241.066
Operating Expenses 215.8189.246159.509132.75293.35105.60983.35968.8468.586
Operating Income 41.38355.84347.56697.52365.09970.05449.16424.5873.146
Operating Income Ratio 0.1030.1420.1480.3070.2930.270.2440.1680.028
Total Other Income Expenses Net -0.350.783-1.0881.6050.0053.505-2.4510.24-0.431
Income Before Tax 41.03356.62646.47999.12765.10473.55946.71224.8274.212
Income Before Tax Ratio 0.1020.1440.1450.3120.2930.2840.2320.170.038
Income Tax Expense 4.2299.2944.82712.9358.4879.726.5583.474-0.123
Net Income 36.80447.33141.65186.19356.61863.83840.15421.3544.335
Net Income Ratio 0.0910.120.130.2710.2550.2460.1990.1460.039
EPS 0.590.750.661.370.91.010.880.470.095
EPS Diluted 0.590.740.661.370.91.010.880.470.095
EBITDA 88.91898.67286.353124.90183.5488.97759.07634.34111.296
EBITDA Ratio 0.2210.250.270.3930.3770.3430.2930.2350.101